Abstract:Nosiheptide, a typical member of the ribosomally synthesized and post-translationally modified peptides (RiPPs), exhibits potent activity against multidrug-resistant Gram-positive bacterial pathogens. The precursor peptide of nosiheptide (NosM) is comprised of a leader peptide with 37 amino acids and a core peptide containing 13 amino acids. To pinpoint elements in the leader peptide that are essential for nosiheptide biosynthesis, a collection of mutants with unique sequence features, including N- and C-terminal motifs, peptide length, and specific sites in the leader peptide, was generated by mutagenesis in vivo. The effects of various mutants on nosiheptide biosynthesis were evaluated. In addition to the necessity of a conserved motif LEIS box, native length and the N-terminal 12 amino acid residues were indispensable, and single-site substitutions of these 12 amino acid residues resulted in changes ranging from a greater-than-5-fold decrease to a 2-fold increase of nosiheptide production, depending on the sites and substituted residues. Moreover, although the C-terminal motif is not conservative, significant effects of this portion on nosiheptide production were also evident. Taken together, the present results further highlight the importance of the leader peptide in nosiheptide biosynthesis, and provide new insights into the diversity and specificity of leader peptides in the biosynthesis of various RiPPs. IMPORTANCE As a representative thiopeptide, nosiheptide exhibits excellent antibacterial activity. Although the biosynthetic gene cluster and several modification steps have been revealed, the presence and roles of the leader peptide within the precursor peptide of the nosiheptide gene cluster remain elusive. Thus, identification of specific elements in the leader peptide can significantly facilitate the genetic manipulation of the gene cluster for increasing nosiheptide production or generating diverse analogues. Given the complexity of the biosynthetic process, the instability of the leader peptide, and the unavailability of intermediates, cocrystallization of intermediates, leader peptide, and modification enzymes is currently not feasible. Therefore, a mutagenesis approach was used to construct a series of leader peptide mutants to uncover a number of crucial and characteristic elements affecting nosiheptide biosynthesis, which moves a considerable distance toward a thorough understanding of the biosynthetic machinery for thiopeptides.

Nosiheptide Biosynthesis Featuring A Unique Indole Side Ring Formation On The Characteristic Thiopeptide Framework

Radical S-Adenosylmethionine Protein NosN Forms the Side Ring System of Nosiheptide by Functionalizing the Polythiazolyl Peptide S-Conjugated Indolic Moiety

Insights into the Substrate Tolerance of Enzymes Involved in the Nosiheptide Biosynthesis Pathway Based on Indolic Acid Moiety

Mutasynthesis Generates Antibacterial Benzothiophenic-Containing Nosiheptide Analogues

Mutational Biosynthesis to Generate Novel Analogs of Nosiheptide Featuring a Fluorinated Indolic Acid Moiety

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Biosynthesis Of The Nosiheptide Indole Side Ring Centers On A Cryptic Carrier Protein Nosj

Structure-based Mechanistic Insights into Terminal Amide Synthase in Nosiheptide-Represented Thiopeptides Biosynthesis

Rerouting the Pathway for the Biosynthesis of the Side Ring System of Nosiheptide: The Roles of NosI, NosJ, and NosK

NosP-Regulated Nosiheptide Production Responds to Both Peptidyl and Small-Molecule Ligands Derived from the Precursor Peptide.

Mutagenesis of NosM Leader Peptide Reveals Important Elements in Nosiheptide Biosynthesis.

Reprogramming the Biosynthesis of Precursor Peptide to Create a Selenazole-Containing Nosiheptide Analogue

Identification of Truncated Form of NosP As a Transcription Factor to Regulate the Biosynthesis of Nosiheptide

Crystallographic Analysis of NosA, Which Catalyzes Terminal Amide Formation in the Biosynthesis of Nosiheptide.

NocU is a Cytochrome P450 Oxygenase Catalyzing N-hydroxylation of the Indolic Moiety During the Maturation of the Thiopeptide Antibiotics Nocathiacins.

Mutagenesis of Precursor Peptide for the Generation of Nosiheptide Analogues

Insight into Bicyclic Thiopeptide Biosynthesis Benefited from Development of a Uniform Approach for Molecular Engineering and Production Improvement

Thiopeptide Biosynthesis Featuring Ribosomally Synthesized Precursor Peptides and Conserved Posttranslational Modifications

Selective biosynthesis of a rhamnosyl nosiheptide by a novel bacterial rhamnosyltransferase

Characterization of NocL Involved in Thiopeptide Nocathiacin I Biosynthesis